| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −4.4× | −1.8× | |
| Price / Book | 0.8× | 2.1× | |
| Price / Sales | 1.8× | 4.0× | |
| Price / Free cash flow | −7.2× | −1.6× | |
| EV / EBITDA | −2.3× | −1.1× | |
| Earnings yield | −22.7% | −14.0% | |
| Free cash flow yield | −13.9% | −9.5% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,267.74 | −2.98% | $1.19T | 59.6× | 77.8% | +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $263.29 | −1.61% | $633.82B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $286.34 | +0.40% | $506B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $419.38 | −1.32% | $376.43B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.78 | −1.67% | $357.18B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.44 | −3.73% | $271.08B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $171.02 | −0.90% | $265.24B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $668.72 | −1.16% | $247.26B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $440.94 | −1.42% | $238.39B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $157.15 | −0.03% | $194.86B | 22.9× | 37.5% | +26.7% |
